Cargando…

Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction

Pre‐clinical studies have indicated that mitoprotective drugs may add cardioprotection beyond rapid revascularization, antiplatelet therapy and risk modification. We review the clinical efficacy of mitoprotective drugs that have progressed to clinical testing comprising cyclosporine A, KAI‐9803, MTP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bøtker, Hans Erik, Cabrera‐Fuentes, Hector Alejandro, Ruiz‐Meana, Marisol, Heusch, Gerd, Ovize, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077531/ https://www.ncbi.nlm.nih.gov/pubmed/31967733 http://dx.doi.org/10.1111/jcmm.14953

Ejemplares similares

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations
por: Hausenloy, Derek J., et al.
Publicado: (2017)

The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia–reperfusion injury via mitoprotection
por: Kheyar, Amel, et al.
Publicado: (2023)

Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
por: Kleinbongard, Petra, et al.
Publicado: (2020)

Reperfusion times of ST-Segment elevation myocardial infarction in hospitals
por: Dong, Shujuan, et al.
Publicado: (2014)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

Factors associated with longer delays in reperfusion in ST-segment elevation myocardial infarction
por: Abreu, Daisy, et al.
Publicado: (2014)

Predictors of Intramyocardial Hemorrhage After Reperfused ST‐Segment Elevation Myocardial Infarction
por: Amier, Raquel P., et al.
Publicado: (2017)

Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction
por: Scholz, Karl Heinrich, et al.
Publicado: (2021)

Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
por: Hausenloy, Derek J., et al.
Publicado: (2016)

Mitoprotective Effects of Centella asiatica (L.) Urb.: Anti-Inflammatory and Neuroprotective Opportunities in Neurodegenerative Disease
por: Wong, Jia Hui, et al.
Publicado: (2021)

Pharmacological protection of reperfusion injury in ST-segment elevation myocardial infarction. Gone with the wind?
por: Tonet, Elisabetta, et al.
Publicado: (2018)

Population access to reperfusion services for ST-segment elevation myocardial infarction in Kerala, India
por: Mathew, Anoop, et al.
Publicado: (2017)

Clinical and angiographic characteristics of patients with spontaneous reperfusion in ST-segment elevation myocardial infarction
por: Wang, Jian, et al.
Publicado: (2020)

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
por: Campo, Gianluca, et al.
Publicado: (2017)

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
por: Lecour, Sandrine, et al.
Publicado: (2021)

Mitoprotective Effects of a Synergistic Nutraceutical Combination: Basis for a Prevention Strategy Against Alzheimer’s Disease
por: Jayatunga, Dona P. W., et al.
Publicado: (2022)

Sex Differences in Timeliness of Reperfusion in Young Patients With ST‐Segment–Elevation Myocardial Infarction by Initial Electrocardiographic Characteristics
por: Gupta, Aakriti, et al.
Publicado: (2018)

Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction
por: Bochaton, Thomas, et al.
Publicado: (2017)

The impact of ischemia-reperfusion injury on the effectiveness of primary angioplasty in ST-segment elevation myocardial infarction
por: Araszkiewicz, Aleksander, et al.
Publicado: (2013)

Effect and Safety of Morphine Use in Acute Anterior ST‐Segment Elevation Myocardial Infarction
por: Bonin, Mickael, et al.
Publicado: (2018)

Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial Dysfunction
por: Pagano, Giovanni, et al.
Publicado: (2020)

Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Characteristics and mechanism of reciprocal ST-segment depression in acute ST segment elevation myocardial infarction: Reciprocal ST-segment depression and ST segment elevation myocardial infarction
por: Gao, Qijun, et al.
Publicado: (2022)

ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies
por: Lecour, Sandrine, et al.
Publicado: (2014)

Adjunctive Catheter-Directed Thrombolysis during Primary PCI for ST-Segment Elevation Myocardial Infarction with High Thrombus Burden
por: Noma, Satsuki, et al.
Publicado: (2022)

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
por: Hausenloy, Derek J., et al.
Publicado: (2010)

Risk Factors of Reperfusion Failure following Primary Angioplasty for ST-Segment Elevation Myocardial Infarction (STEMI)
por: Sanati, Hamid Reza, et al.
Publicado: (2013)

Comparison of Reperfusion Strategies for ST‐Segment–Elevation Myocardial Infarction: A Multivariate Network Meta‐analysis
por: Fazel, Reza, et al.
Publicado: (2020)

Aging-Related Disorders and Mitochondrial Dysfunction: A Critical Review for Prospect Mitoprotective Strategies Based on Mitochondrial Nutrient Mixtures
por: Pagano, Giovanni, et al.
Publicado: (2020)

Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment
por: Zhong, Yucheng, et al.
Publicado: (2015)

Relationship between CMR-derived parameters of ischemia/reperfusion injury and the timing of CMR after reperfused ST-segment elevation myocardial infarction
por: Masci, Pier-Giorgio, et al.
Publicado: (2018)

Adjunctive Manual Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials
por: Deng, Song-Bai, et al.
Publicado: (2014)

ST Segment Elevation with Normal Coronaries
por: Sethi, Pooja, et al.
Publicado: (2016)

False-positive ST-segment elevation
por: Tanabe, Junya, et al.
Publicado: (2020)

Cause of ST-segment elevation on electrocardiogram
por: Soh, Rodney Yu-Hang, et al.
Publicado: (2022)

ST-Segment Elevation: An Unexpected Culprit
por: Sá Couto, David, et al.
Publicado: (2023)

Lenticular mitoprotection. Part B: GSK-3β and regulation of mitochondrial permeability transition for lens epithelial cells in atmospheric oxygen
por: Brooks, Morgan M., et al.
Publicado: (2013)

Extent of infarct size and microvascular obstruction following unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction
por: Rajewska-Tabor, Justyna, et al.
Publicado: (2015)

Intracoronary Poloxamer 188 Prevents Reperfusion Injury in a Porcine Model of ST-Segment Elevation Myocardial Infarction
por: Bartos, Jason A., et al.
Publicado: (2016)

Influence of angiographic spontaneous coronary reperfusion on long-term prognosis in patients with ST-segment elevation myocardial infarction
por: Li, Xiaoming, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ltj9fhni1ik5sb82ogbu2vclvh